References
- B. P. Grone and K. P. Maruska, "A second corticotropin-releasing hormone gene (CRH2) is conserved across vertebrate classes and expressed in the hindbrain of a basal neopterygian fish, the spotted gar", J. Comp. Neurol., Vol. 523, pp. 2015.
- R. L. Hauger, D. E. Grigoriadis, M. F. Dallman, P. M. Plotsky, W. W. Vale, and F. M. Dautzenberg, "Current status of the nomenclature for receptors for corticotropin-releasing factor and their ligands", Pharmacol. Rev., Vol. 55, pp. 21-26, 2003. https://doi.org/10.1124/pr.55.1.3
- N. Sato, K. Takagi, T. Suzuki, Y. Miki, S. Tanaka, S. Nagase, H. Warita, S. Fukudo, F. Sato, H. Sasano, and K. Ito, "Immunolocalization of corti-cotropin-releasing hormone (CRH) and its receptors (CRHR1 and CRHR2) in human endometrial car-cinoma: CRHR1 as a potent prognostic factor", Int. J. Gynecol. Cancer, Vol. 24, pp. 1549-1557, 2014. https://doi.org/10.1097/IGC.0000000000000269
- F. Stamatelou, E. Deligeoroglou, N. Vrachnis, S. Iliodromiti, Z. Iliodromiti, S. Sifakis, G. Far-makides, and G. Creatsas, "Corticotropin-releasing hormone and progesterone plasma levels association with the onset and progression of labor", Clin. Exp. Obstet. Gynecol., 2013
- F. C. Raadsheer, J. J. van Heerikhuize, P. J. Lucas- sen, and W. J. Hoogendijk, "Corticotropin-releasing hormone mRNA levels in the paraventricular nucleus of patients with Alzheimer's disease and depression", Am. J. Psychiatry, Vol. 152, pp. 1372-1376, 1995. https://doi.org/10.1176/ajp.152.9.1372
- H.-B. Fan, T. Zhang, K. Sun, S.-P. Song, S.-B. Cao, H.-L. Zhang, and W. Shen, "Corticotropin-releasing factor mediates bone cancer induced pain through neuronal activation in rat spinal cord", Tumor Bilogy, Vol. 36, pp. 9559-9565, 2015. https://doi.org/10.1007/s13277-015-3670-1
- V. Coric, H. H. Feldman, D. A. Oren, A. Shekhar, J. Pultz, R. C. Dockens, X. Wu, K. A. Gentile, S.?P. Huang, E. Emison, T. Delmonte, B. B. D'Souza, D. L. Zimbroff, J. A. Grebb, A. W. Goddard, and E. G. Stock, "Multicenter, randomized, double-blind, active comparator and placebo-controlled trial of a corticotropin-releasing factor receptor-1 antagonist in generalized anxiety disorder", Depress. Anxiety, Vol. 27, pp. 417-425, 2010 https://doi.org/10.1002/da.20695
- E. M. Jutkiewicz, S. K. Wood, and J. H. Woods, "The effects of CRF antagonists, antalarmin, CP154,526, LWH234, and R121919, in the forced swim test and on swim-induced increases in adre- nocorticotropin in rats", Psychopharmacology (Berl.), Vol. 180, pp. 215-223, 2005. https://doi.org/10.1007/s00213-005-2164-z
- B. Binneman, D. Feltner, S. Kolluri, Y. Shi, R. Qiu, and T. Stiger, "A 6-week randomized, placebo-con- trolled trial of CP-316,311 (a selective CRH1 antag- onist) in the treatment of major depression", Am. J. Psychiatry, Vol. 165, pp. 617-620, 2008. https://doi.org/10.1176/appi.ajp.2008.07071199
- R. Pastor, C. S. McKinnon, A. C. Scibelli, S. Burkhart-Kasch, C. Reed, A. E. Ryabinin, S. C. Coste, M. P. Stenzel-Poore, and T. J. Phillips, "Corticotropin-releasing factor-1 receptor involvement in behavioral neuroadaptation to ethanol: A urocortin1-independent mechanism", Proc. Natl. Acad. Sci. U.S.A., Vol. 105, pp. 9070-9075, 2008. https://doi.org/10.1073/pnas.0710181105
- S. K. Nagarajan and T. Madhavan, "3D-QSAR studies of 8-substituted-2-aryl-5-alkylaminoquino-lines as corticotropin-releasing factor-1 receptor antagonists", J. Chosun Natural Sci., Vol. 8, pp. 176-183, 2015. https://doi.org/10.13160/ricns.2015.8.3.176
- (a) S. K. Nagarajan, T. Madhavan, "Comparative molecular similarity indices analysis (CoMSIA) of 8-substituted-2-aryl-5-alkylaminoquinolines as corticotropin-releasing factor-1 receptor antagonists", J. Chosun Natural Sci., Vol. 9, pp. 241-248, 2016. https://doi.org/10.13160/ricns.2016.9.4.241
- Y. Shen, J. Maupetit, P. Derreumaux, and P. Tufféry, "Improved PEP-FOLD approach for peptide and miniprotein structure prediction", J. Chem. Theory Comput., Vol. 10, pp. 4745-4758. 2014. https://doi.org/10.1021/ct500592m
- S. C. Lovell, I. W. Davis, W. B. Arendall III, P. I. W. de Bakker, J. M. Word, M. G. Prisant, J. S. Richardson, and D. C. Richardson, "Structure validation by Ca geometry: f, y and Cb deviation", Proteins, Vol. 50, pp. 437-450, 2003. https://doi.org/10.1002/prot.10286
- C. Colovos and T. O. Yeates," Verification of protein structures: patterns of nonbonded atomic inter-actions", Protein Sci., Vol. 2, pp. 1511-1519. 1993. https://doi.org/10.1002/pro.5560020916
- M. Wiederstein and M. J. Sippl, "ProSA-web: inter- active web service for the recognition of errors in three-dimensional structures of proteins", Nucleic Acids Res., Vol. 35, pp. W407-W410. 2007. https://doi.org/10.1093/nar/gkm290
- S. R. Comeau, D. W. Gatchell, S. Vajda, and C. Camacho, "ClusPro: an automated docking and dis- crimination method for the prediction of protein complexes", Bioinformatics, Vol. 20, pp. 45-50. 2003.
- S. C. Comeau, D. W. Gatchell, S. Vajda, and C. Camacho, "ClusPro: a fully automated algorithm for protein-protein docking", Nucleic Acids Res, Vol. 32, pp. 96-99, 2004.
- D. Kozakov, D. Beglov, T. Bohnuud, S. Mottarella, B. Xia, D. R. Hall, and S. Vajda, "How good is automated protein docking?", Proteins, Vol. 81, pp. 2159-2166, 2013. https://doi.org/10.1002/prot.24403
- M. F. Lensink and S. J. Wodak, "Docking, scoring, and affinity prediction in CAPRI", Proteins, Vol. 81, pp. 2082-2095. 2013. https://doi.org/10.1002/prot.24428
- D. Kozakov, R. Brenke, S. R. Comeau, and S. Vajda, "PIPER: An FFT-based protein docking program with pairwise potentials", Proteins, Vol. 65, pp. 392-406, 2006. https://doi.org/10.1002/prot.21117
- S. K. Nagarajan, "Protein-Protein Interaction Analysis of KiSS1-Derived Peptide Receptor with Kisspeptin-10 and Kisspeptin-15", J. Chosun Natural Sci., Vol. 11, pp. 9-13, 2018.
- B. Sathya, "Hologram Based QSAR Analysis of Xanthine Oxidase Inhibitors", J. Chosun Natural Sci., Vol. 10, pp. 202-208, 2017.